Home › Interstitial Lung Diseases › NCT00470327

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Interstitial lung disease

Exclusion Criteria:

* Does not have Interstitial lung disease

About the study

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Sponsor: University of Chicago · Participants: 4,000 · Started: 2005-09

Contact the study team

• Vanita Patel, MPH · Phone: 773-702-1012

Official record on ClinicalTrials.gov — NCT00470327

Locations in the U.S.

Conditions

• Interstitial Lung Diseases
• Idiopathic Pulmonary Fibrosis
• Sarcoidosis
• Connective Tissue Disorders

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.